Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

788
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
788
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression01:05

Long-term Depression

33.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.5K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

793
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
793
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

918
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
918

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human rights-based mental healthcare: new developments, introducing a themed series of papers.

BJPsych open·2026
Same author

Negative symptoms in schizophrenia: Methodological challenges and emerging solutions for outcome measurement.

Neuroscience applied·2026
Same author

Subjective perceptions of negative symptoms among outpatients with schizophrenia and their relatives or caregivers: Definitions, importance, measurement, and desired improvement.

Schizophrenia research·2026
Same author

Negative symptoms of schizophrenia demonstrate measurement bias across sociodemographic variables.

Schizophrenia research·2026
Same author

Understanding the burden of cognitive impairment associated with schizophrenia: Results from the international LUCIA study.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Schizophrenia and accelerated ageing: systematic review and future research directions.

The British journal of psychiatry : the journal of mental science·2026

Related Experiment Video

Updated: Mar 1, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K

Primary, Enduring Negative Symptoms: An Update on Research.

Brian Kirkpatrick1, Armida Mucci2, Silvana Galderisi3

  • 1Department of Psychiatry and Behavioral Sciences, University of Nevada Reno School of Medicine, Reno, NV.

Schizophrenia Bulletin
|June 3, 2017
PubMed
Summary
This summary is machine-generated.

Disease-deficit schizophrenia (DS) may be a distinct condition characterized by primary negative symptoms. Evidence suggests differences in white matter and metabolic measures between DS and non-deficit schizophrenia patients.

Keywords:
deficit schizophrenianegative symptomsnosologypsychopathologyschizophrenia

More Related Videos

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

15.9K
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

18.8K

Related Experiment Videos

Last Updated: Mar 1, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

15.9K
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

18.8K

Area of Science:

  • Neuroscience
  • Psychiatry

Background:

  • Schizophrenia may comprise distinct subtypes, including disease-deficit schizophrenia (DS) characterized by primary negative symptoms.
  • Accumulating evidence supports the hypothesis of DS as a separate disease entity within schizophrenia spectrum disorders.

Purpose of the Study:

  • To review and synthesize recent evidence supporting the disease-deficit schizophrenia hypothesis.
  • To explore potential neurobiological and cognitive differences between deficit and non-deficit schizophrenia patient groups.

Main Methods:

  • Review of existing literature on white matter changes, metabolic measures, and symptom clusters in schizophrenia.
  • Analysis of studies investigating reward and defeatist beliefs in relation to negative symptoms.
  • Examination of risk factors and broader clinical correlates of deficit features.

Main Results:

  • Widespread white matter alterations may be more prevalent in deficit schizophrenia patients, potentially linked to early brain development.
  • Pre-treatment metabolic differences observed between deficit and non-deficit groups.
  • Negative symptoms in DS may represent two distinct subgroups with differing correlates, suggesting further heterogeneity within DS.

Conclusions:

  • The evidence supports disease-deficit schizophrenia as a potentially distinct condition requiring further investigation.
  • Differences in neurobiology and symptom presentation warrant targeted research for improved treatment strategies.
  • Exploring deficit features in other neuropsychiatric disorders with negative symptoms may broaden understanding.